Based in its Basel, Switzerland HQ, Jacob is the global head of antitrust at Sandoz, a world leading generic and biosimilars company. Jacob advises on all antitrust issues arising in Sandoz’ business operations including antitrust compliance, advocacy, policy, investigations, M&A and more.

Jacob joined Sandoz in October 2023 from Takeda Pharmaceuticals, where he had a dual role as head of legal, Nordics and head of antitrust Europe, based in Stockholm. Jacob came to Takeda as a result of its acquisition of Shire in 2019, having joined Shire in 2016 after relocating back to Sweden from the UK where he had been with GSK as its London HQ-based assistant general counsel, primarily responsible for competition law matters. Prior to joining GSK in 2008, he held various senior in-house roles after moving to the UK in 2000.

A Swedish national, he started his career with the Swedish Competition Authority, serving for four years before joining a global law firm in Stockholm to practice competition law. Jacob earned his Swedish law degree at Uppsala University and an LLM in European law at the University of Essex. He has taught competition law at Swedish universities and written several books and articles on the subject. Jacob is also a regular speaker at various international competition law conferences.

Ingrid Vandenborre is the partner in charge of Skadden’s Brussels office and co-head of Skadden’s European Antitrust/Competition practice. Her practice focuses on EU and international merger control and competition law enforcement.

Ms. Vandenborre has been consistently named as a leading practitioner in Who’s Who Legal guides in both competition and life sciences, as well as repeatedly in Chambers Global, Chambers Europe and The Legal 500 EMEA. In 2023, she was named Antitrust & Competition Lawyer of the Year at the Women in Business Law EMEA Awards. Ms. Vandenborre also was named Lawyer of the Year by Global Competition Review in 2022, was selected to GCR’s Women in Antitrust list in 2021 and was recognized for her representation of Aspen Pharmacare in relation to the European Commission’s (EC) Article 102 investigation of the company’s pricing practices, which was named European Behavioural Matter of the Year by the publication. In addition, she was named a 2021 Competition MVP by Law360, a 2021 Litigation Star for Belgium - Competition/Antitrust by Benchmark Litigation Europe and Competition Lawyer of the Year at Benchmark Litigation Europe’s 2020 Awards, which also recognized her work advising Aspen as an Impact Case of the Year. She currently serves as nongovernmental adviser to the intergovernmental International Competition Network.

Ms. Vandenborre has significant experience in Article 101 and 102 issues in relation to cartel arrangements, as well as vertical and competitive agreements and alleged abuse of dominance. She also has a significant merger control practice, extending to the EC and the U.K. Competition and Markets Authority.